DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹2,230 Cr | ₹1,388 Cr | ₹1,831 Cr | ₹1,665 Cr | ₹1,367 Cr |
What is the latest Total Non-Current Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹2,230 Cr |
Mar2024 | ₹1,388 Cr |
Mar2023 | ₹1,831 Cr |
Mar2022 | ₹1,665 Cr |
Mar2021 | ₹1,367 Cr |
How is Total Non-Current Liabilities of DISHMAN CARBOGEN AMCIS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2,230 Cr | 60.62 | |
Mar2024 | ₹1,388 Cr | -24.19 | |
Mar2023 | ₹1,831 Cr | 9.96 | |
Mar2022 | ₹1,665 Cr | 21.86 | |
Mar2021 | ₹1,367 Cr | - |
Compare Total Non-Current Liabilities of peers of DISHMAN CARBOGEN AMCIS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DISHMAN CARBOGEN AMCIS | ₹4,498.6 Cr | -2.5% | 7.5% | 60.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,218.0 Cr | -0.7% | 3% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,158.0 Cr | 1.9% | 8.3% | 5.8% | Stock Analytics | |
CIPLA | ₹126,710.0 Cr | 0.5% | 0.7% | -2.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,586.0 Cr | -0.1% | NA | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,496.0 Cr | -2% | -5.4% | -7.5% | Stock Analytics |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DISHMAN CARBOGEN AMCIS | -2.5% |
7.5% |
60.3% |
SENSEX | 1.6% |
2.1% |
2.6% |
You may also like the below Video Courses